Showing 74,901 - 74,920 results of 108,424 for search '(( 5 ((ppm decrease) OR (a decrease)) ) OR ( a ((point decrease) OR (nn decrease)) ))', query time: 1.55s Refine Results
  1. 74901
  2. 74902
  3. 74903
  4. 74904
  5. 74905
  6. 74906
  7. 74907

    shRNA knockdown of p53 expression reverses dinaciclib-induced apoptosis. by Brijal M. Desai (390996)

    Published 2013
    “…D) The knockdown of p53 led to decreased pRB (ser807/811) and a decrease in cleaved PARP in cells treated with dinaciclib. …”
  8. 74908
  9. 74909
  10. 74910
  11. 74911
  12. 74912
  13. 74913
  14. 74914
  15. 74915
  16. 74916

    image_1.tif by Jessica D. Falcone (5008673)

    Published 2018
    “…Endothelial adhesion markers revealed a significant increase in expression at 14 weeks, while CD45, a pan-leukocyte marker, significantly decreased at 14 weeks. …”
  17. 74917

    Effect of silkworm (<i>Bombyx mori</i>) pupae oil supplementation on enteric methane emission and methanogens diversity in sheep by G. Thirumalaisamy (9647478)

    Published 2020
    “…<i>In vitro</i> study indicated a reduction of 22% in CH<sub>4</sub> production with 2% oil supplementation. …”
  18. 74918

    Supplementary Material for: Office-Based Sinus Surgery for Cystic Fibrosis Chronic Rhinosinusitis by Spielman D.B. (9857870)

    Published 2020
    “…<b><i>Methods:</i></b> This is a prospective cohort study conducted at a tertiary care academic medical center with a CF Foundation-accredited care center. …”
  19. 74919

    Abdeg technology for the treatment of myasthenia gravis: efgartigimod drug experience by Jéssica Barreto Ribeiro Dos Santos (12400044)

    Published 2022
    “…</p> <p>Efgartigimod is a human IgG1–derived Fc fragment modified at five residues to increase its affinity for the neonatal Fc receptor by Abdeg technology. …”
  20. 74920

    Measured anisotropy in different illumination modes, for analysis receptor assemblies in the cell membrane. by Miklos Erdelyi (1675021)

    Published 2014
    “…(iv) Upon agonist treatment, the labeled P2Y1 receptors readily form dimers in the plasma membrane with almost 100% efficiency. (v) Application of a highly potent P2Y1R selective antagonist, completely reverses the agonist-induced decrease in anisotropy in the TIRF mode, confirming the P2Y1R involvement.…”